Pressmeddelanden, rapporter och bolagsmeddelande för Curasight
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight expands its strategy and strengthen its position as a theranostic company
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight expands its strategy and strengthen its position as a theranostic company
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight strengthens its strategic position with the acquisition of TRT Innovations ApS
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight strengthens its strategic position with the acquisition of TRT Innovations ApS
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Phase II study of uPAR-PET in neuroendocrine tumor patients demonstrates strong prognostic value and supports potential future use of uPAR-targeted radionuclide therapy
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight presents at the SEB Nordic Healthcare Seminar 2022 and at Kapital Partner
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight attends the J.P. Morgan Healthcare Conference and presents at HC Andersen Capital
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight attends the J.P. Morgan Healthcare Conference and presents at HC Andersen Capital
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Hanne Damgaard Jensen joins Curasight A/S as Chief Development Officer (CDO)
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Transaction with shares in Curasight A/S made by managerial employee